New Enterprise Associates 16, L.p.

Affiliations

  • at Marker Therapeutics Inc. (MRKR), 2024-12-23
  • at Neuehealth Inc. (NEUE), 2024-10-03
  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2023-06-15
  • Large Shareholder at Akouos Inc. (AKUS), 2022-12-02
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2022-05-26
  • Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2022-04-13
  • Large Shareholder at Metacrine Inc. (MTCR), 2021-12-27
  • Other at Regulus Therapeutics Inc. (RGLS), 2021-03-17
  • Large Shareholder at Black Diamond Therapeutics Inc. (BDTX), 2020-01-30
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MRKR $3.20 554,250 $1,773,600.00 1,625,678 2024-12-23 Filing
TRVI $1.90 2,631,578 $4,999,998.20 10,421,428 2022-04-11 Filing
TRVI $0.00 1,851,852 $0.00 7,789,850 2021-10-18 Filing
MRKR $1.75 5,714,285 $9,999,998.75 10,714,285 2021-03-16 Filing
MTCR $13.00 769,230 $9,999,990.00 3,060,527 2020-09-18 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GNCA $0.08 4,445,093 $362,719.59 0 2022-05-25 Filing
GNCA $0.07 5,931,843 $387,942.53 4,445,093 2022-05-24 Filing
MTCR $0.91 170,932 $155,565.21 2,563,257 2021-12-22 Filing
MTCR $1.00 288,768 $289,287.78 2,734,189 2021-12-22 Filing
MTCR $1.32 37,570 $49,629.97 3,022,957 2021-12-10 Filing